BRAF and melanoma: In BRAF-mutant melanoma, DTP cells emerging after MAPK inhibitor treatment demonstrate increased intracellular calcium signaling via P2X7-mediated ERK reactivation, which supports survival in the drug-tolerant idling state (Stauffer et al., 2024).